Clinical Trials Logo

Acne Scars - Mixed Atrophic and Hypertrophic clinical trials

View clinical trials related to Acne Scars - Mixed Atrophic and Hypertrophic.

Filter by:
  • None
  • Page 1

NCT ID: NCT04827680 Enrolling by invitation - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 20 subjects requesting treatment of acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

NCT ID: NCT04606134 Active, not recruiting - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring

Start date: February 13, 2020
Phase: N/A
Study type: Interventional

To evaluate the efficacy of a tripeptide/hexapeptide topical (Alastin Regenerating Skin Nectar with TriHex Technology®) in wound healing and scar reduction following Erbium:YAG hybrid resurfacing laser for acne scarring compared to the standard of post-procedure care consisting of a bland moisturizer.

NCT ID: NCT04559022 Enrolling by invitation - Acne Clinical Trials

Pilot Study Investigating the Efficacy of Fat Grafting as a Treatment for Male and Female Facial Acne Scarring

Start date: October 30, 2020
Phase: N/A
Study type: Interventional

This single-center, clinical trial consists of a one autologous fat grafting treatment followed by 3-month and 6-month post-treatment visits in order to assess the efficacy of fat grafting when used by men and women with facial acne scars.

NCT ID: NCT04252352 Not yet recruiting - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Treatment of Acne Scars With Fractional CO2 Laser Versus Radio-frequency Microneedling

Start date: February 2020
Phase: N/A
Study type: Interventional

The study is a prospective, randomized, controlled, intra-person split-face trial with blinded evaluations. The objective is to compare efficacy and adverse effects of ablative fractional CO2 laser resurfacing versus radio-frequency microneedling for treatment of atrophic acne scars in the facial area. Two comparable areas with acne scars on each side of the face are treated. One area will be treated with fractional CO2 laser and the other area with radio-frequency microneedling. Outcome measures will be assessed by blinded investigators and included subjects at baseline before treatment and at follow-up visits 2-4 days and 1 and 3 months post-treatment. On-site assessment and OCT will be performed at the time of the visits. OCT scans will be offered to the subjects and are optional. Clinical photos are used for documentation. 15 participants will be recruited. The participants will be recruited to enter the trial in the clinic by investigators at the Department of Dermatology, Bispebjerg Hospital, and must meet the inclusion criteria (at least 18 years of age, acne scars in the facial area, comparable atrophic acne scars on each side of the face, fitzpatrick skintype I-III) to be eligible to enter the study. No personal remuneration will be awarded the investigators. None of the collaborators have any personal economic interest in the study. Participants will not receive remuneration. All treatments are performed at the Department of Bispebjerg Hospital and patients are covered by the Hospital's patient insurance. The declaration of Helsinki will be respected as well as the standards of good clinical research. Respect for privacy as well as physically and mentally integrity of the participants will be maintained. The study will be performed in accordance with Danish Health care authorities.

NCT ID: NCT04057768 Completed - Wrinkle Clinical Trials

Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

Start date: August 19, 2019
Phase: N/A
Study type: Interventional

The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.

NCT ID: NCT03988049 Completed - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Comparison of 1,550 and 755 Laser in a Split-face Trial

Start date: March 8, 2017
Phase: N/A
Study type: Interventional

Clinical Trial comparing the 1,550-nanometer fractionated photothermolysis system laser to the 755 nanometer picosecond laser using a split-face (Right-Left) comparison. Patients will receive laser treatments at week 0, week 4, and week 8. Photographs will be taken prior to laser treatment at each visit, and at the week 24 follow-up visit. Photographs will be reviewed by blinded assessors to rate each side of the face and change from baseline photos.

NCT ID: NCT03514771 Completed - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Early Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral Isotretinoin

Start date: January 28, 2016
Phase: N/A
Study type: Interventional

Patients who have completed have completed a cumulative dose of >=120miligram/kilogram oral isotretinoin within the last 30 days, and has mild to moderate acne scarring will be randomized, into a right-left comparison study using Fraxel DUAL (Solta Medical) laser on one side of the face, and no treatment on the other side of the face. Subejcts will receive treatments at week 0, week 4, and week 8. Photographs will be taken after each treatment, 7 days after each treatment, and 4 months after last treatment. Photographs will be reviewed by blind assessors who will analyze the pre- and post-treatment photographs to measure change.

NCT ID: NCT03284333 Active, not recruiting - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars

Start date: July 27, 2017
Phase: N/A
Study type: Interventional

The purpose of this pivotal investigation is to evaluate the efficacy and safety of the Cutera enlighten multi-wavelength 532 nm and 1064 nm Nd:YAG picosecond pulse duration laser and an investigational micro-lens array (MLA) handpiece attachment for improvement of acne scars.

NCT ID: NCT02592993 Active, not recruiting - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

Performance of PicoWayTM Picosecond Fractional Laser for Acne Scars

Start date: May 23, 2015
Phase: N/A
Study type: Interventional

Open-label, prospective study. Up to 60 healthy adult volunteers seeking facial acne scars treatment, males or females of 18 to 75 years of age, from up to 3 investigational sites.